» Articles » PMID: 34999988

Association of Post-transplantation Anellovirus Viral Load with Kidney Transplant Rejection in Children

Overview
Journal Pediatr Nephrol
Specialties Nephrology
Pediatrics
Date 2022 Jan 9
PMID 34999988
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Post-transplantation immunosuppressive therapy reduces the risk of graft rejection but raises the risk of infection and malignancy. A biomarker of the level of immunosuppression can be helpful in monitoring immunosuppressive therapy. Inverse correlation between Torque teno virus (TTV) from the Anelloviridae (AV) family load and immune competence was described in previous studies. The aim of this study was to analyze the association between AV family viruses' kinetics and the risk for graft rejection in the first year after kidney transplantation in children.

Methods: The titers of three genera (TTV, TTMDV, and TTMV) from the AV family were monitored by real-time PCR in consecutive samples from children before and after kidney transplantation.

Results: Twenty-one children who underwent kidney transplantation were enrolled. Five out of 21 patients experienced acute graft rejection within a year from transplantation. We found that in patients who experienced graft rejection, the median titers of TTV and total AV titers at 5-6 months post-transplantation were lower than in those who did not. Using a threshold determined by ROC analysis, significant differences in TTV and total AV load were found between patients who had or did not have graft rejection (p = 0.002 and 0.004, respectively). No association was found between the dominance of any AV genus titer and the likelihood of rejection.

Conclusion: This pilot study suggests that children after kidney transplantation with low TTV and total AV titers 5-6 months post-transplantation are at increased risk for graft rejection within a year after transplantation. A higher resolution version of the Graphical abstract is available as Supplementary information.

Citing Articles

Torquetenovirus from bronchoalveolar lavage fluid as a biomarker for lung infection among immunocompromised hosts.

Zhu Z, Wang Y, Ning W, Liu C, Chen C Biomark Med. 2024; 18(13-14):581-591.

PMID: 38982729 PMC: 11370955. DOI: 10.1080/17520363.2024.2366148.


The mysterious anelloviruses: investigating its role in human diseases.

Sabbaghian M, Gheitasi H, Shekarchi A, Tavakoli A, Poortahmasebi V BMC Microbiol. 2024; 24(1):40.

PMID: 38281930 PMC: 10823751. DOI: 10.1186/s12866-024-03187-7.


Torquetenovirus Loads in Peripheral Blood Predict Both the Humoral and Cell-Mediated Responses to SARS-CoV-2 Elicited by the mRNA Vaccine in Liver Transplant Recipients.

Minosse C, Matusali G, Meschi S, Grassi G, Francalancia M, DOffizi G Vaccines (Basel). 2023; 11(11).

PMID: 38005988 PMC: 10674741. DOI: 10.3390/vaccines11111656.


Impact of polymorphisms in genes orchestrating innate immune responses on replication kinetics of Torque teno virus after kidney transplantation.

Redondo N, Rodriguez-Goncer I, Parra P, Albert E, Gimenez E, Ruiz-Merlo T Front Genet. 2022; 13:1069890.

PMID: 36482892 PMC: 9723237. DOI: 10.3389/fgene.2022.1069890.

References
1.
Fishman J . Infection in solid-organ transplant recipients. N Engl J Med. 2007; 357(25):2601-14. DOI: 10.1056/NEJMra064928. View

2.
Kaczorowska J, van der Hoek L . Human anelloviruses: diverse, omnipresent and commensal members of the virome. FEMS Microbiol Rev. 2020; 44(3):305-313. PMC: 7326371. DOI: 10.1093/femsre/fuaa007. View

3.
Spandole S, Cimponeriu D, Berca L, Mihaescu G . Human anelloviruses: an update of molecular, epidemiological and clinical aspects. Arch Virol. 2015; 160(4):893-908. DOI: 10.1007/s00705-015-2363-9. View

4.
De Vlaminck I, Khush K, Strehl C, Kohli B, Luikart H, Neff N . Temporal response of the human virome to immunosuppression and antiviral therapy. Cell. 2013; 155(5):1178-87. PMC: 4098717. DOI: 10.1016/j.cell.2013.10.034. View

5.
Li L, Deng X, da Costa A, Bruhn R, Deeks S, Delwart E . Virome analysis of antiretroviral-treated HIV patients shows no correlation between T-cell activation and anelloviruses levels. J Clin Virol. 2015; 72:106-13. PMC: 4697764. DOI: 10.1016/j.jcv.2015.09.004. View